Preclinical Efficacy and Immunological Safety of FR104, an Antagonist Anti-CD28 Monovalent Fab′ Antibody

Autor: Poirier, N., Mary, C., Dilek, N., Hervouet, J., Minault, D., Blancho, G., Vanhove, B. *
Zdroj: In American Journal of Transplantation October 2012 12(10):2630-2640
Databáze: ScienceDirect